MétaCan
← all works

p53, cancer and the immune response

2020· review· en· 339 citations· W3009145316 on OpenAlex· 10.1242/jcs.237453

Why is this work in the frame?

A frame that forgets how it found something cannot be audited. These are the routes that admitted this work.

Canadian funderA Canadian agency funded it. The work may carry no Canadian affiliation at all.

No Canadian affiliation. An affiliation-only frame — the usual design — would never have seen this work. It is one of the works that make the case for inverting the frame.

Machine scores (provisional)

Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.

The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.

Opus teacher head0.028
GPT teacher head0.337
Teacher spread
0.309 · how far apart the two teachers sit on this one work
Validation status
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from it

Abstract

) has been established in many studies, but it is now clear that the p53 status of the cancer cell also has a profound impact on the immune response. Loss or mutation of p53 in cancers can affect the recruitment and activity of myeloid and T cells, allowing immune evasion and promoting cancer progression. p53 can also function in immune cells, resulting in various outcomes that can impede or support tumour development. Understanding the role of p53 in tumour and immune cells will help in the development of therapeutic approaches that can harness the differential p53 status of cancers compared with most normal tissue.

Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.

The record

Venue
Journal of Cell Science
Topic
Cancer-related Molecular Pathways
Field
Medicine
Canadian institutions
Funders
Medical Research CouncilCanadian Institutes of Health ResearchMedical Research Council CanadaCancer Research UKWellcome TrustFrancis Crick InstituteEuropean Molecular Biology Organization
Keywords
BiologyImmune systemCancerSuppressorCancer researchEvasion (ethics)Cancer cellImmunologyMyeloidGenetics
Has abstract in OpenAlex
yes